Roflumilast 31722-0676

Product NDC

31722-0676

Manufacturer: Camber Pharmaceuticals, Inc.
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: April 18, 2023
Listing Expires: December 31, 2026
Application: ANDA208213

Need to source Roflumilast? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Roflumilast	250 ug/1

Drug Class

Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]

Packaging Options(2)

31722-0676-32

2 BLISTER PACK in 1 CARTON (31722-676-32) / 10 TABLET in 1 BLISTER PACK (31722-676-31)

View →

31722-0676-36

1 BLISTER PACK in 1 CARTON (31722-676-36) / 28 TABLET in 1 BLISTER PACK (31722-676-35)

View →